Nanosphere Health Sciences Inc
NanoSphere Health Sciences Inc., a nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada. It offers NanoSphere Delivery System, a platform using nanotechnology in the biodelivery of supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, animal health, and other industries. NanoSphere Health Sciences … Read more
Nanosphere Health Sciences Inc (NSHSF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.048x
Based on the latest financial reports, Nanosphere Health Sciences Inc (NSHSF) has a cash flow conversion efficiency ratio of 0.048x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-66.14K) by net assets ($-1.37 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Nanosphere Health Sciences Inc - Cash Flow Conversion Efficiency Trend (2005–2024)
This chart illustrates how Nanosphere Health Sciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Nanosphere Health Sciences Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nanosphere Health Sciences Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
New Tymbal Resources Ltd.
V:NTB
|
0.038x |
|
ValueInvest Global Akk KL
CO:VAIGAKA
|
N/A |
|
COGNEX - Dusseldorf Stock Exchang
DU:CGZ
|
0.036x |
|
The Shyft Group Inc
F:SP8
|
-0.018x |
|
Marine Bancorp of Florida Inc
PINK:MBOF
|
N/A |
|
Multifiling Mitra Indonesia
JK:MFMI
|
0.242x |
|
BEKAERT - Dusseldorf Stock Exchang
DU:BK8N
|
N/A |
|
HPE-P-C
PINK:HPE-P-C
|
N/A |
Annual Cash Flow Conversion Efficiency for Nanosphere Health Sciences Inc (2005–2024)
The table below shows the annual cash flow conversion efficiency of Nanosphere Health Sciences Inc from 2005 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-1.22 Million | $-35.92K | 0.030x | -14.48% |
| 2023-12-31 | $-1.56 Million | $-53.70K | 0.035x | -33.11% |
| 2022-12-31 | $-1.31 Million | $-67.66K | 0.052x | -14.24% |
| 2021-12-31 | $-1.08 Million | $-64.68K | 0.060x | +85.01% |
| 2020-12-31 | $-1.45 Million | $-47.26K | 0.033x | -97.23% |
| 2019-12-31 | $-919.49K | $-1.08 Million | 1.174x | +130.37% |
| 2018-12-31 | $837.88K | $-3.24 Million | -3.866x | -1028.30% |
| 2017-12-31 | $3.68 Million | $-1.26 Million | -0.343x | -17.92% |
| 2016-12-31 | $787.23K | $-228.72K | -0.291x | -148.01% |
| 2015-12-31 | $-88.57K | $-53.60K | 0.605x | -78.43% |
| 2014-12-31 | $-134.84K | $-378.25K | 2.805x | +44.27% |
| 2013-12-31 | $-376.36K | $-731.84K | 1.945x | +655.77% |
| 2012-12-31 | $6.38 Million | $-2.23 Million | -0.350x | -24.28% |
| 2011-12-31 | $5.86 Million | $-1.65 Million | -0.282x | +70.79% |
| 2010-12-31 | $4.92 Million | $-4.74 Million | -0.964x | -216.48% |
| 2009-12-31 | $489.35K | $404.82K | 0.827x | +117.58% |
| 2008-12-31 | $129.54K | $-609.51K | -4.705x | -25325.26% |
| 2007-12-31 | $6.38 Million | $-118.12K | -0.019x | +82.08% |
| 2006-12-31 | $281.06K | $-29.03K | -0.103x | -4827.31% |
| 2005-12-31 | $313.35K | $684.52 | 0.002x | -- |